Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (13)

Search Parameters:
Keywords = asymptomatic BV

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
13 pages, 670 KiB  
Article
Investigation of Causative Agents of Vaginitis in Symptomatic and Asymptomatic Women in Konya, Turkey
by Duygu Beder, Fatma Esenkaya Taşbent, Fatma Kılıç Hamzaoğlu, Emine Türen Demir, Mehmet Özdemir and Gökçe Kader Arslan
Parasitologia 2025, 5(2), 15; https://doi.org/10.3390/parasitologia5020015 - 1 Apr 2025
Viewed by 650
Abstract
A significant portion of women encounter vaginal infections at some point in their lives. These infections have many effects such as infertility, pelvic inflammatory disease (PID), severe disseminated infections, and complications affecting fetal health during pregnancy. Vaginal infections can be symptomatic or asymptomatic, [...] Read more.
A significant portion of women encounter vaginal infections at some point in their lives. These infections have many effects such as infertility, pelvic inflammatory disease (PID), severe disseminated infections, and complications affecting fetal health during pregnancy. Vaginal infections can be symptomatic or asymptomatic, thereby concealing their presence. This study aimed to determine the frequency and causative agents of vaginal infections in symptomatic and asymptomatic women in Konya. The study included 200 patients aged > 18 years who visited the gynecology clinic for any reason and provided informed consent. Patients who reported at least one of the symptoms of vaginal discharge, burning, or itching were categorized into the symptomatic group, while those without any of these complaints were categorized into the asymptomatic group. Vaginal swab samples collected from the patients were evaluated for bacterial vaginosis (BV) using the Nugent scoring method on Gram-stained smears. Trichomonas vaginalis was investigated through Giemsa-stained microscopic examination and polymerase chain reaction (PCR) analysis. Samples were also cultured on routine media to analyze fungal and bacterial growth. A total of 74% of the patients were symptomatic, and 26% were asymptomatic and were admitted to the gynecology outpatient clinic for reasons other than vaginitis. According to the Nugent scoring system, BV was observed in 21.6% of the symptomatic group and 13.5% of the asymptomatic group. T. vaginalis was detected in only seven patients (3.5%) through microscopic examination and PCR. Among the patients with T. vaginalis, five were in the symptomatic group, and two were in the asymptomatic group. The rate of vaginal candidiasis was found to be 34.5% in the symptomatic group and 21.2% in the asymptomatic group. Aerobic vaginitis was observed in 12.8% of the symptomatic group and 7.7% of the asymptomatic group. The positivity rates for BV, vaginal candidiasis, and trichomoniasis in asymptomatic patients are concerning. Considering the fetal complications and chronic effects of vaginal infections, the decision to establish screening programs in the asymptomatic patient group should be based on national data, considering the prevalence of the pathogen in the region and its outcomes. Full article
Show Figures

Figure 1

18 pages, 1852 KiB  
Article
Ceragenins Prevent the Development of Murine Vaginal Infection Caused by Gardnerella vaginalis
by Urszula Wnorowska, Ewelina Piktel, Tamara Daniluk, Paulina Paprocka, Paul B. Savage, Bonita Durnaś and Robert Bucki
Pharmaceuticals 2024, 17(11), 1445; https://doi.org/10.3390/ph17111445 - 29 Oct 2024
Viewed by 1708
Abstract
Background/Objectives: Bacterial vaginosis (BV), an infection caused primarily by Gardnerella vaginalis, is the most prevalent vaginal infection. Although BV is often characterized by an asymptomatic course, it can lead to considerable health complications. Currently, BV therapy choices are limited, and available treatments [...] Read more.
Background/Objectives: Bacterial vaginosis (BV), an infection caused primarily by Gardnerella vaginalis, is the most prevalent vaginal infection. Although BV is often characterized by an asymptomatic course, it can lead to considerable health complications. Currently, BV therapy choices are limited, and available treatments are complicated by concerns about antibiotic resistance. Ceragenins, which together comprise an innovative class of low molecular-weight, cholic acid-based antibacterial agents, have emerged as potential alternatives to conventional treatments. Methods: This study investigates (i) the antibacterial activity of ceragenins against G. vaginalis in in vitro experimental settings at varied pH, and (ii) the effectiveness and anti-inflammatory properties of CSA-13 in a G. vaginalis-induced bacterial vaginosis animal model. Results and Conclusions: We demonstrate that ceragenins, particularly CSA-13, maintain their antibacterial efficacy throughout pH range of 4.5–7, with the highest activity observed at neutral pH (7.0). Additionally, in an animal model, beneficial effects of ceragenins are attributed to anti-inflammatory properties of these compounds, making these compounds promising agents as potential new treatment options against G. vaginalis-associated vaginal infections. Full article
(This article belongs to the Special Issue Development of Antibacterial Drugs to Combat Drug-Resistant Bacteria)
Show Figures

Figure 1

15 pages, 2042 KiB  
Article
A Multi-Strain Oral Probiotic Improves the Balance of the Vaginal Microbiota in Women with Asymptomatic Bacterial Vaginosis: Preliminary Evidence
by Simone Filardo, Marisa Di Pietro, Paola Mastromarino, Maria Grazia Porpora and Rosa Sessa
Nutrients 2024, 16(20), 3469; https://doi.org/10.3390/nu16203469 - 14 Oct 2024
Cited by 2 | Viewed by 6773
Abstract
Background/Objectives: the vaginal microbiota is known to confer protection in the genital ecosystem, due to the predominance of different Lactobacillus species, playing a crucial role in women’s health; alterations in the composition of the microbial communities in the vagina can be associated with [...] Read more.
Background/Objectives: the vaginal microbiota is known to confer protection in the genital ecosystem, due to the predominance of different Lactobacillus species, playing a crucial role in women’s health; alterations in the composition of the microbial communities in the vagina can be associated with the development of bacterial vaginosis (BV). Current therapy for BV involves oral or intravaginal administration of metronidazole or clindamycin, albeit the high recurrence rates suggest a need for alternative therapeutic tools, such as probiotics. Herein, the diversity and composition of vaginal microbiota in women with asymptomatic BV was investigated before and after the oral administration of a multi-strain probiotic formulation. Methods: a prospective observational pilot study with pre–post design was carried out from 1 June 2022, to 31 December 2022, on reproductive-age women with asymptomatic BV, as diagnosed via Nugent score, and matched healthy controls. The probiotic was administered to all study participants as acid-resistant oral capsules (twice daily), and a vaginal swab was collected at baseline and after 2 months of treatment, for the metagenomic analysis of 16s rDNA. Results: the diversity and richness of the vaginal microbiota in women with BV were significantly reduced after 2 months of supplementation with the oral probiotic, as evidenced by measures of α-diversity. Interestingly, some bacterial genera typically associated with dysbiosis, such as Megasphaera spp., were significantly decreased; whereas, at the same time, Lactobacillus spp. Doubled. Conclusions: our preliminary results suggest that the multi-strain oral probiotic is a beneficial treatment specifically targeting the dysbiotic vaginal microenvironment. Full article
(This article belongs to the Section Prebiotics and Probiotics)
Show Figures

Figure 1

13 pages, 991 KiB  
Article
Characterization of Progranulin Gene Mutations in Portuguese Patients with Frontotemporal Dementia
by Maria Rosário Almeida, Miguel Tábuas-Pereira, Inês Baldeiras, Marisa Lima, João Durães, João Massano, Madalena Pinto, Catarina Cruto and Isabel Santana
Int. J. Mol. Sci. 2024, 25(1), 511; https://doi.org/10.3390/ijms25010511 - 29 Dec 2023
Cited by 3 | Viewed by 1882
Abstract
In Portugal, heterozygous loss-of-function mutations in the progranulin (GRN) gene account for approximately half of the genetic mediated forms of frontotemporal dementia (FTD). GRN mutations reported thus far cause FTD through a haploinsufficiency disease mechanism. Herein, we aim to unveil the [...] Read more.
In Portugal, heterozygous loss-of-function mutations in the progranulin (GRN) gene account for approximately half of the genetic mediated forms of frontotemporal dementia (FTD). GRN mutations reported thus far cause FTD through a haploinsufficiency disease mechanism. Herein, we aim to unveil the GRN mutation spectrum, investigated in 257 FTD patients and 19 family members from the central/north region of Portugal using sequencing methods. Seven different pathogenic variants were identified in 46 subjects including 40 patients (16%) and 6 relatives (32%). bvFTD was the most common clinical presentation among the GRN mutation patients, who showed a global pattern of moderate-to-severe frontotemporoparietal deficits in the neuropsychological evaluation. Interestingly, two mutations were novel (p.Thr238Profs*18, p.Leu354Profs*16), and five were previously described, although three of them only in the Portuguese population, suggesting a population-specific GRN mutational spectrum. The subjects harboring a GRN mutation showed a significant reduction in serum PGRN levels, supporting the pathogenic nature of these variants. This work broadens the mutation spectrum of GRN and the identification of the underlying GRN mutations provided an accurate genetic counselling and allowed the enrolment of subjects with GRN mutations (both asymptomatic and symptomatic) in ongoing clinical trials, which is essential to test new drugs for the disease. Full article
(This article belongs to the Special Issue Molecular Mechanisms of Dementia 2.0)
Show Figures

Figure 1

13 pages, 2569 KiB  
Article
Development of Quantitative Real-Time PCR and Loop-Mediated Isothermal Amplification Assays for the Surveillance and Diagnosis of Herpes B Virus Infection
by Murasaki Amano, Krittiga Sapkanarak, Wipaporn Thbthimthong, Suthirote Meesawat, Taratorn Kemthong, Nutchanat Suttisan, Haruka Abe, Suchinda Malaivijitnond and Jiro Yasuda
Viruses 2023, 15(10), 2086; https://doi.org/10.3390/v15102086 - 13 Oct 2023
Cited by 3 | Viewed by 2357
Abstract
Herpes B virus (BV) is a zoonotic virus which can be transmitted from macaques to humans, which is often associated with high mortality rates. Because macaques often exhibit asymptomatic infections, individuals who come into contact with these animals face unexpected risks of BV [...] Read more.
Herpes B virus (BV) is a zoonotic virus which can be transmitted from macaques to humans, which is often associated with high mortality rates. Because macaques often exhibit asymptomatic infections, individuals who come into contact with these animals face unexpected risks of BV infections. A serological test is widely performed to investigate BV infections. However, the assay’s sensitivity and specificity appeared to be inadequate, and it does not necessarily indicate ongoing viral shedding. Here, we developed LAMP and qPCR assays aiming to detect BVs with a high sensitivity and specificity in various macaque species and validated them using oral swab samples collected from 97 wild cynomolgus macaques living in Thailand. Our LAMP and qPCR assays detected more than 50 and 10 copies of the target sequences per reaction, respectively. The LAMP assay could detect BV within 25 min, indicating its advantages for the rapid detection of BV. Collectively, our findings indicated that both assays developed in this study exhibit advantages and usefulness for BV surveillance and the diagnosis of BV infections in macaques. Furthermore, for the first time, we determined the partial genome sequences of BVs detected in cynomolgus macaques in Thailand. Phylogenetic analysis revealed the species-specific evolution of BV within macaques. Full article
(This article belongs to the Special Issue Controlling Zoonotic Viral Diseases from One Health Perspective 2025)
Show Figures

Figure 1

21 pages, 685 KiB  
Review
Bacterial Vaginosis and Post-Operative Pelvic Infections
by Afroditi Ziogou, Eleftherios Ziogos, Ilias Giannakodimos, Alexios Giannakodimos, Stavros Sifakis, Petros Ioannou and Sotirios Tsiodras
Healthcare 2023, 11(9), 1218; https://doi.org/10.3390/healthcare11091218 - 25 Apr 2023
Cited by 15 | Viewed by 4885
Abstract
Bacterial vaginosis (BV) represents a condition in which the normal protective Lactobacilli, especially those that produce H2O2, are replaced by high quantities of facultative anaerobes, leading to gynecologic and obstetric post-operative complications. BV is an important cause of obstetric [...] Read more.
Bacterial vaginosis (BV) represents a condition in which the normal protective Lactobacilli, especially those that produce H2O2, are replaced by high quantities of facultative anaerobes, leading to gynecologic and obstetric post-operative complications. BV is an important cause of obstetric and gynecological adverse sequelae and it could lead to an increased risk of contracting sexually transmitted infections such as gonorrhea, genital herpes, Chlamydia, Trichomonas, and human immunodeficiency virus. Herein, we reviewed bacterial vaginosis and its association with post-operative pelvic infections. In Obstetrics, BV has been associated with increased risk of preterm delivery, first-trimester miscarriage in women undergoing in vitro fertilization, preterm premature rupture of membranes, chorioamnionitis, amniotic fluid infections, postpartum and postabortal endomyometritis as well as postabortal pelvic inflammatory disease (PID). In gynecology, BV increases the risk of post-hysterectomy infections such as vaginal cuff cellulitis, pelvic cellulitis, pelvic abscess, and PID. BV is often asymptomatic, can resolve spontaneously, and often relapses with or without treatment. The American College of Obstetricians and Gynecologists recommends testing for BV in women having an increased risk for preterm delivery. Women with symptoms should be evaluated and treated. Women with BV undergoing gynecological surgeries must be treated to reduce the frequency of post-operative pelvic infections. Metronidazole and clindamycin are the mainstays of therapy. Currently, there is no consensus on pre-surgery screening for BV; decisions are made on a case-by-case basis. Full article
(This article belongs to the Special Issue Fertility-Sparing Gynaecological Surgery)
Show Figures

Figure 1

13 pages, 7639 KiB  
Article
Home-Based Electrochemical Rapid Sensor (HERS): A Diagnostic Tool for Bacterial Vaginosis
by Melissa Banks, Farbod Amirghasemi, Evelyn Mitchell and Maral P. S. Mousavi
Sensors 2023, 23(4), 1891; https://doi.org/10.3390/s23041891 - 8 Feb 2023
Cited by 10 | Viewed by 6764
Abstract
Bacterial vaginosis (BV) is the most frequently occurring vaginal infection worldwide, yet it remains significantly underdiagnosed as a majority of patients are asymptomatic. Untreated BV poses a serious threat as it increases one’s risk of STI acquisition, pregnancy complications, and infertility. We aim [...] Read more.
Bacterial vaginosis (BV) is the most frequently occurring vaginal infection worldwide, yet it remains significantly underdiagnosed as a majority of patients are asymptomatic. Untreated BV poses a serious threat as it increases one’s risk of STI acquisition, pregnancy complications, and infertility. We aim to minimize these risks by creating a low-cost disposable sensor for at-home BV diagnosis. A clinical diagnosis of BV is most commonly made according to the Amsel criteria. In this method, a fish-like odor, caused by increased levels of trimethylamine (TMA) in vaginal fluid, is used as a key diagnostic. This paper outlines the development of a Home-Based Electrochemical Rapid Sensor (HERS), capable of detecting TMA in simulated vaginal fluid (sVF). Instead of odor-based detection of volatilized TMA, we identify TMA in trimethylammonium form by utilizing HERS and a potentiometric readout. We fabricated the ion selective electrode using a carbon-black-coated cotton string and a TMA-selective membrane consisting of calix[4]arene and sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate. When paired with a standard reference electrode, our device was able to quantify TMA concentration in deionized (DI) water, as well as sVF samples at multiple pH levels with a clinically relevant limit of detection (8.66 µM, and theoretically expected Nernstian slope of 55.14 mV/decade). Full article
(This article belongs to the Special Issue Women’s Special Issue Series: Sensors)
Show Figures

Figure 1

13 pages, 1786 KiB  
Article
High-Throughput Sequencing-Based Analysis of Changes in the Vaginal Microbiome during the Disease Course of Patients with Bacterial Vaginosis: A Case–Control Study
by Jing Gao, Yiqian Peng, Nanyan Jiang, Youhao Shi and Chunmei Ying
Biology 2022, 11(12), 1797; https://doi.org/10.3390/biology11121797 - 10 Dec 2022
Cited by 4 | Viewed by 3023
Abstract
Background: The vaginal microbiome is closely associated with the onset and recurrence of bacterial vaginosis (BV). In the present study, the state of vaginal microbiota during the onset and post-treatment asymptomatic stages of BV were compared to that of a healthy population to [...] Read more.
Background: The vaginal microbiome is closely associated with the onset and recurrence of bacterial vaginosis (BV). In the present study, the state of vaginal microbiota during the onset and post-treatment asymptomatic stages of BV were compared to that of a healthy population to evaluate the changes in different characteristic bacteria during the onset, progression, and remission of BV. Methods: A case–control study was performed to explore these changes. Women with clinical symptoms of BV were divided into the disease group (M) and case–control group (C) based on the Nugent score. Subjects in the disease group whose symptoms were resolved after the treatment were assigned to the treated group (T) and healthy subjects were recruited into the normal control (N) group. The V3–V4 hypervariable regions of bacterial 16S rRNA genes were sequenced on the Illumina MiSeq platform. Results: The N harbored the highest number of detected species and a higher abundance of microbiota; they had a significantly higher abundance of Lactobacillus and different bacterial community composition compared to the other three groups. In group M, Gardnerella vaginalis was the dominant species, whereas Lactobacillus iners was predominant in the other three groups. While Lactobacillus was more commonly present in Group C compared to group M. it was significantly increased in group T. Alpha diversity analysis of bacterial communities revealed significant differences in community richness and diversity among all four groups (p < 0.05). Significant differences in the distribution of various bacterial communities among the different groups were also observed (p < 0.05). Specifically, the abundance of eight bacterial taxa (Megasphaera, Aerococcus christensenii, Clostridiales, Gardnerella, Peptostreptococcus, Veillonellaceae, Akkermansia, Coriobacteriales) differed significantly among the four groups (p < 0.05). Conclusion: Significant differences in the composition and alpha diversity of the vaginal microbiota at different stages of BV and the distribution of bacterial communities were observed among the investigated groups. In addition to Gardnerella, Sneathia sanguinegens and Prevotella timonensis play an important role in the pathogenesis of BV. The appearance of BV-like clinical symptoms was closely associated with the decrease in Prevotella and Atopobium vaginae populations. Full article
(This article belongs to the Section Developmental and Reproductive Biology)
Show Figures

Figure 1

18 pages, 3998 KiB  
Article
Pathogenicity of Asymptomatically Residing Fusarium Species in Non-Gramineous Plants and Weeds to Spring Wheat under Greenhouse Conditions
by Evelina Zavtrikovienė, Andrii Gorash, Gražina Kadžienė, Neringa Matelionienė and Skaidrė Supronienė
Pathogens 2022, 11(12), 1467; https://doi.org/10.3390/pathogens11121467 - 4 Dec 2022
Cited by 3 | Viewed by 2403
Abstract
Despite significant efforts in recent decades to combat Fusarium head blight (FHB), this disease remains one of the most important and widely studied diseases of wheat and other cereal plants. To date, studies have focused on small grain cereals as hostplants for these [...] Read more.
Despite significant efforts in recent decades to combat Fusarium head blight (FHB), this disease remains one of the most important and widely studied diseases of wheat and other cereal plants. To date, studies have focused on small grain cereals as hostplants for these pathogens, but it was recently discovered that asymptomatic non-gramineous plants and weeds can serve as alternative sources of fungi associated with FHB. The aim of this study was to evaluate the pathogenicity of Fusarium avenaceum, F. culmorum, F. graminearum and F. sporotrichioides isolated from non-gramineous plants and weed species to spring wheat under greenhouse conditions. A total of 91 Fusarium isolates, including 45 from weeds and 46 from non-gramineous plants were floret inoculated at mid anthesis. The FHB incidence and severity (%) of inoculated heads and the area under the disease progress curve (AUDPC) were calculated. To determine yield losses, the weight of 1000 grains (TGW) was evaluated. Results of the research showed that FHB severity (%) values in Fusarium spp.-inoculated heads from non-gramineous plants varied from 9.3% to 69.6% and AUDPC values ranged from 161.5% to 1044.6%. TGW was most significantly reduced by the F. culmorum isolates BN26r and BN39fl from Brassica napus and isolates BV15.1l and BV142.1pe from Beta vulgaris (37%, 30%, 28.8% and 31.8% respectively, compared to the water control). In Fusarium-inoculated heads from weeds, FHB severity values ranged from 6.2% to 81.0% and AUDPC values varied from 134.2% to 1206.6%. TGW was most significantly decreased by CBP1401r isolate from Capsella bursa-pastoris (52%). The study results suggest that the pathogenicity of Fusarium species isolated from different hosts to wheat more strongly depends on the Fusarium species and strain than the hostplant. Under greenhouse conditions, F. culmorum strain groups obtained from weeds, non-gramineous plants and Triticum were more pathogenic to wheat than the water control and other Fusarium species. Full article
(This article belongs to the Special Issue Current Research on Fusarium)
Show Figures

Figure 1

16 pages, 740 KiB  
Review
The Role of Lactic Acid in the Management of Bacterial Vaginosis: A Systematic Literature Review
by Werner Mendling, Maged Atef El Shazly and Lei Zhang
Future Pharmacol. 2022, 2(3), 198-213; https://doi.org/10.3390/futurepharmacol2030014 - 29 Jun 2022
Cited by 10 | Viewed by 21227
Abstract
Bacterial vaginosis (BV) is a common infection characterized by an imbalance in the vaginal microbiome. Alongside the extensive research for effective therapies, treatment recommendations for symptomatic BV with antibiotics have been developed and are currently available. However, the recurrence of BV remains a [...] Read more.
Bacterial vaginosis (BV) is a common infection characterized by an imbalance in the vaginal microbiome. Alongside the extensive research for effective therapies, treatment recommendations for symptomatic BV with antibiotics have been developed and are currently available. However, the recurrence of BV remains a considerable challenge given that about 60% of women experience BV relapse within six months after initial treatment. In addition, clear guidelines on the treatment of asymptomatic BV during pregnancy or for BV mixed infections are still missing. Lactic acid has been put forward as a potential treatment or for prophylaxis of BV due to its ability to restore the imbalance of the vaginal microbiota and to promote the disruption of vaginal pathogenic bacterial biofilms, which might trigger BV recurrence. This review evaluates the clinical evidence regarding the efficacy and prophylactic potential of lactic acid in BV through a systematic literature search. In addition, a treatment regimen consisting of lactic acid as a standalone treatment or in combination with current recommended therapies for practice is suggested based on these findings and stratified according to BV severity, pregnancy status, and coincidence with vulvovaginal candidosis (VVC) or trichomoniasis. Full article
Show Figures

Figure 1

25 pages, 623 KiB  
Review
The Role of Genital Tract Microbiome in Fertility: A Systematic Review
by Salvatore Giovanni Vitale, Federico Ferrari, Michał Ciebiera, Magdalena Zgliczyńska, Agnese Maria Chiara Rapisarda, Giada Maria Vecchio, Alessandra Pino, Giuseppe Angelico, Anna Knafel, Gaetano Riemma, Pasquale De Franciscis and Stefano Cianci
Int. J. Mol. Sci. 2022, 23(1), 180; https://doi.org/10.3390/ijms23010180 - 24 Dec 2021
Cited by 75 | Viewed by 10574
Abstract
The human microbiome plays a crucial role in determining the health status of every human being, and the microbiome of the genital tract can affect the fertility potential before and during assisted reproductive treatments (ARTs). This review aims to identify and appraise studies [...] Read more.
The human microbiome plays a crucial role in determining the health status of every human being, and the microbiome of the genital tract can affect the fertility potential before and during assisted reproductive treatments (ARTs). This review aims to identify and appraise studies investigating the correlation of genital microbiome to infertility. Publications up to February 2021 were identified by searching the electronic databases PubMed/MEDLINE, Scopus and Embase and bibliographies. Only full-text original research articles written in English were considered eligible for analysis, whereas reviews, editorials, opinions or letters, case studies, conference papers, and abstracts were excluded. Twenty-six articles were identified. The oldest studies adopted the exclusive culture-based technique, while in recent years PCR and RNA sequencing based on 16S rRNA were the most used technique. Regardless of the anatomical site under investigation, the Lactobacillus-dominated flora seems to play a pivotal role in determining fertility, and in particular Lactobacillus crispatus showed a central role. Nonetheless, the presence of pathogens in the genital tract, such as Chlamydia trachomatis, Gardnerella vaginalis, Ureaplasma species, and Gram-negative stains microorganism, affected fertility also in case of asymptomatic bacterial vaginosis (BV). We failed to identify descriptive or comparative studies regarding tubal microbiome. The microbiome of the genital tract plays a pivotal role in fertility, also in case of ARTs. The standardization of the sampling methods and investigations approaches is warranted to stratify the fertility potential and its subsequent treatment. Prospective tubal microbiome studies are warranted. Full article
(This article belongs to the Special Issue Molecular Research on Obstetrics and Gynecology)
Show Figures

Figure 1

18 pages, 16187 KiB  
Article
Distinct Functional Traits of Lactobacilli from Women with Asymptomatic Bacterial Vaginosis and Normal Microbiota
by Rinku Pramanick and Clara Aranha
Microorganisms 2020, 8(12), 1949; https://doi.org/10.3390/microorganisms8121949 - 9 Dec 2020
Cited by 8 | Viewed by 3566
Abstract
Asymptomatic bacterial vaginosis (BV) in reproductive-age women has serious obstetric and gynecological consequences. Despite its high incidence, the behavior of vaginal lactobacilli in asymptomatic BV is unknown. We analyzed the functional properties of previously isolated vaginal lactobacilli from asymptomatic women with normal, intermediate, [...] Read more.
Asymptomatic bacterial vaginosis (BV) in reproductive-age women has serious obstetric and gynecological consequences. Despite its high incidence, the behavior of vaginal lactobacilli in asymptomatic BV is unknown. We analyzed the functional properties of previously isolated vaginal lactobacilli from asymptomatic women with normal, intermediate, and BV microbiota. Lactic acid and antimicrobial activity against seven urogenital pathogens were evaluated from lactobacilli cell-free culture supernatants (CFCs) (n = 207) after 48 h incubation in MRS. Lactobacilli isolates were used to evaluate H2O2, autoaggregation and coaggregation with C. albicans. Lactobacilli from normal microbiota produced more d-lactate than lactobacilli from intermediate and asymptomatic BV (p = 0.007). L. plantarum, L. fermentum and L. reuteri produced greater d-lactate whereas L. rhamnosus, L. crispatus, L. johnsonii were greater producers of l-lactate. Interspecies positive correlation was observed in the lactic acid contents of CFCs. Distribution of H2O2-producing lactobacilli did not vary significantly among the groups. When lactic acid isomers were considered, species from intermediate and BV microbiota clustered together with each other and distinctly from species of normal microbiota. Broad-spectrum antagonism (≥90% inhibition) against E. coli, C. albicans, S. aureus, P. aeruginosa, G. vaginalis, N. gonorrhoeae, S. agalactiae were displayed by 46.86% (97) of isolates. Our study highlights the differential functional properties of vaginal lactobacilli from women with normal microbiota and asymptomatic BV. Full article
(This article belongs to the Section Public Health Microbiology)
Show Figures

Figure 1

15 pages, 2006 KiB  
Article
The Dwindling Microbiota of Aerobic Vaginitis, an Inflammatory State Enriched in Pathobionts with Limited TLR Stimulation
by Eline F. M. Oerlemans, Sander Wuyts, Gert Bellen, Stijn Wittouck, Ilke De Boeck, Kateryna Ruban, Camille Nina Allonsius, Marianne F. L. van den Broek, Gilbert G. G. Donders and Sarah Lebeer
Diagnostics 2020, 10(11), 879; https://doi.org/10.3390/diagnostics10110879 - 28 Oct 2020
Cited by 31 | Viewed by 6236
Abstract
While bacterial vaginosis (BV) is a well-known type of vaginal dysbiosis, aerobic vaginitis (AV) is an inflammatory condition that remains understudied and under-recognised. It predisposes women to serious complications including urogenital infections and pregnancy problems. Here, we investigated the bacterial community in AV [...] Read more.
While bacterial vaginosis (BV) is a well-known type of vaginal dysbiosis, aerobic vaginitis (AV) is an inflammatory condition that remains understudied and under-recognised. It predisposes women to serious complications including urogenital infections and pregnancy problems. Here, we investigated the bacterial community in AV to explore its possible role in AV pathogenesis. We collected vaginal lavage fluid samples of women (n = 58) classified by wet-mount microscopy as suffering from AV or BV and included an asymptomatic reference group without signs of AV or BV. AV samples showed reduced absolute abundances of bacteria in general and specifically of lactobacilli by qPCR, but 16S rRNA gene sequencing and amplicon sequence variant analysis revealed that Lactobacillus remained the dominant taxon in 25% of the AV samples studied. The other AV samples showed high relative abundances of Streptococcus agalactiae and, unexpectedly, the anaerobes Gardnerella vaginalis and Prevotella bivia in more than half of the AV samples studied. Yet, despite increased relative abundance of these potential pathogens or pathobionts in the AV bacterial communities, the AV samples only slightly stimulated Toll-like receptor 4 and showed reduced activation of Toll-like receptor 2/6, receptors of two pathways central to mucosal immunity. Our findings indicate that the reduced total bacterial abundance with associated enrichment in certain pathobionts in AV might be mainly a consequence of the inflammatory conditions and/or altered hormonal regulation rather than bacteria being a major cause of the inflammation. Full article
(This article belongs to the Special Issue Diagnosis of Genital Infections)
Show Figures

Figure 1

Back to TopTop